Universe · entity

Eversept Partners, LP

Institutional manager (13F) · CIK 1697013
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $1.4B
#IssuerValueShares
1UNITED THERAPEUTICS CORP DEL$157M264,271
2ABIVAX SA$104M934,423
3GSK PLC$99M1,785,175
4VERA THERAPEUTICS INC$87M2,173,286
5NATERA INC$77M384,713
6SYNDAX PHARMACEUTICALS INC$67M2,885,622
7CELLDEX THERAPEUTICS INC NEW$57M1,788,016
8VAXCYTE INC$54M924,193
9BROOKDALE SR LIVING INC$49M3,568,555
10IONIS PHARMACEUTICALS INC$47M632,100
11HCA HEALTHCARE INC$37M79,229
12WELLTOWER INC$36M180,953
13HEALTHPEAK PROPERTIES INC$33M1,981,070
14INSULET CORP$30M143,546
15BIOCRYST PHARMACEUTICALS INC$29M3,039,820
16GERON CORP$28M18,834,883
17OMEGA HEALTHCARE INVS INC$26M585,680
18LIQUIDIA CORPORATION$26M677,392
19COMMUNITY HEALTH SYS INC NEW$26M8,677,281
20AVANTOR INC$23M2,974,287
21QIAGEN NV$22M545,330
22ENCOMPASS HEALTH CORP$19M194,104
23ELI LILLY & CO$17M19,000
24TRAVERE THERAPEUTICS INC$16M542,610
25CYTOMX THERAPEUTICS INC.$15M3,188,514
26REPLIGEN CORP$14M120,785
27BETA BIONICS INC$14M1,414,838
28VIRIDIAN THERAPEUTICS INC$14M713,269
29ARCUTIS BIOTHERAPEUTICS INC$14M576,580
30ARDELYX INC$13M2,229,446
31LTC PPTYS INC$12M321,046
32BIOMARIN PHARMACEUTICAL INC$12M207,768
33CHEMED CORP NEW$12M31,057
34PHARVARIS N V$11M406,960
35PENNANT GROUP INC$10M312,178
36NEWAMSTERDAM PHARMA COMPANY$9M285,764
37PALISADE BIO INC$9M4,987,499
38MODERNA INC$8M159,708
39VIKING THERAPEUTICS INC$8M239,110
40ICON PLC$8M68,688
41XENON PHARMACEUTICALS INC$8M129,574
42REVVITY INC$7M84,854
43AGIOS PHARMACEUTICALS INC$7M200,000
44STRUCTURE THERAPEUTICS INC$7M138,036
45BIO-TECHNE CORP$7M125,896
46GLAUKOS CORP$6M60,214
47TENET HEALTHCARE CORP$6M29,512
48MADRIGAL PHARMACEUTICALS INC$5M10,000
49INTUITIVE SURGICAL INC$5M11,119
50ESPERION THERAPEUTICS INC NE$5M1,735,963
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.